Bremelanotide

Also called PT-141

What it is, the potential benefits being studied, and what the evidence supports right now.

Well establishedUsed medically for a specific purpose

01 • Start here

Potential benefits being studied.

Acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.

  • Mood & stress
  • Hormone & reproductive health

02 • Why it stands out

The simple explanation.

Bremelanotide is getting attention for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.

03 • Research highlight

Why researchers are interested.

Bremelanotide is best known for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women, with a defined role supported by human experience.

Evidence detailsStudy limits, status, and safety context

Study summary: Controlled trials supported the product's labeled benefit on sexual desire and distress outcomes in the indicated population.

What to keep in mind: The approval does not establish broad sexual-performance, bodybuilding, or wellness benefits.

Potential benefits describe research questions, not a promise that a product will produce the same result in a person.